IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Cardiovascular and Hematological Agents in Medicinal Chemistry

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.37

h-Index

2022-2023

 42

Rank

2022-2023

 16207

SJR

2022-2023

 0.268

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Cardiovascular and Hematological Agents in Medicinal Chemistry
Abbreviation Cardiovasc. Hematol. Agents Med. Chem.
Publication Type Journal
Subject Area, Categories, Scope Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)
h-index 42
Overall Rank/Ranking 16207
SCImago Journal Rank (SJR) 0.268
Impact Score 1.37
Publisher Bentham Science Publishers B.V.
Country United Arab Emirates
ISSN 18715257
Best Quartile Q3
Coverage History 2006-2022




About Cardiovascular and Hematological Agents in Medicinal Chemistry


Cardiovascular and Hematological Agents in Medicinal Chemistry is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3). It is published by Bentham Science Publishers B.V.. The overall rank of Cardiovascular and Hematological Agents in Medicinal Chemistry is 16207. According to SCImago Journal Rank (SJR), this journal is ranked 0.268. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 42. The best quartile for this journal is Q3.

The ISSN of Cardiovascular and Hematological Agents in Medicinal Chemistry journal is 18715257. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cardiovascular and Hematological Agents in Medicinal Chemistry is cited by a total of 97 articles during the last 3 years (Preceding 2022).


Cardiovascular and Hematological Agents in Medicinal Chemistry Impact IF 2022-2023


The Impact IF 2022 of Cardiovascular and Hematological Agents in Medicinal Chemistry is 1.37, which is computed in 2023 as per its definition. Cardiovascular and Hematological Agents in Medicinal Chemistry IF is decreased by a factor of 0.69 and approximate percentage change is -33.5% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Cardiovascular and Hematological Agents in Medicinal Chemistry Impact IF 2023 Prediction


Impact IF 2022 of Cardiovascular and Hematological Agents in Medicinal Chemistry is 1.37. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Cardiovascular and Hematological Agents in Medicinal Chemistry. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.37
2021 2.06
2020 1.85
2019 1.31
2018 1.03
2017 0.81
2016 0.70
2015 0.84
2014 1.23

Cardiovascular and Hematological Agents in Medicinal Chemistry h-index


  Table Setting

Cardiovascular and Hematological Agents in Medicinal Chemistry has an h-index of 42. It means 42 articles of this journal have more than 42 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Cardiovascular and Hematological Agents in Medicinal Chemistry ISSN


The ISSN of Cardiovascular and Hematological Agents in Medicinal Chemistry is 18715257. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Cardiovascular and Hematological Agents in Medicinal Chemistry Rank and SCImago Journal Rank (SJR)


The overall rank of Cardiovascular and Hematological Agents in Medicinal Chemistry is 16207. According to SCImago Journal Rank (SJR), this journal is ranked 0.268. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Cardiovascular and Hematological Agents in Medicinal Chemistry by Year


Year SJR
2023/2024 Coming Soon
2022 0.268
2021 0.409
2020 0.415
2019 0.246
2018 0.307
2017 0.336
2016 0.359
2015 0.515
2014 0.532

Ranking of Cardiovascular and Hematological Agents in Medicinal Chemistry by Year


Year Ranking
2023/2024 Coming Soon
2022 16207
2021 11865
2020 11754
2019 16312
2018 13527
2017 12342
2016 11930
2015 8973
2014 8526

Cardiovascular and Hematological Agents in Medicinal Chemistry Publisher


Table Setting

Cardiovascular and Hematological Agents in Medicinal Chemistry is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Cardiovascular and Hematological Agents in Medicinal Chemistry is Cardiovasc. Hematol. Agents Med. Chem.. This abbreviation ('Cardiovasc. Hematol. Agents Med. Chem.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Cardiovascular and Hematological Agents in Medicinal Chemistry


If your research field is/are related to Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

Cardiovascular and Hematological Agents in Medicinal Chemistry latest impact IF is 1.37. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.06 (2021) and 0.70 (2016), respectively, in the last 9 years. Moreover, its average IS is 1.24 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry has an SJR (SCImago Journal Rank) of 0.268, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.532 in 2014 and the lowest being 0.246 in 2019. Furthermore, the average SJR of the Cardiovascular and Hematological Agents in Medicinal Chemistry over the previous 9-year period stands at 1.24.


What's the latest h-index of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The latest h-index of the Cardiovascular and Hematological Agents in Medicinal Chemistry is 42.


Who's the publisher of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.


What's the current ranking of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry is currently ranked 16207 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 8526 in 2014 and its lowest position of 16312 in 2019.


What's the abbreviation or short name for the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The standard ISO4 abbreviation for the Cardiovascular and Hematological Agents in Medicinal Chemistry is Cardiovasc. Hematol. Agents Med. Chem..


Is the "Cardiovascular and Hematological Agents in Medicinal Chemistry" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Cardiovascular and Hematological Agents in Medicinal Chemistry is classified as a journal that the Bentham Science Publishers B.V. publishes.


What's the scope or major areas of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry encompasses the following areas:

  • Cardiology and Cardiovascular Medicine
  • Hematology
  • Medicine (miscellaneous)
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry is assigned the following International Standard Serial Numbers (ISSN): 18715257.


What's the best quartile of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The best quartile for the Cardiovascular and Hematological Agents in Medicinal Chemistry is Q3 (2022).


What's the coverage history of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry coverage history can be summarized as follows: 2006-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
European Union Politics journal 2250 SAGE Publications Ltd 72 2.64
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Clinical Medicine and Research journal 16602 Marshfield Clinic 60 1.06
International Journal of Mathematical Education in Science and Technology journal 10040 Taylor and Francis Ltd. 39 1.33
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
International Journal of Parallel, Emergent and Distributed Systems journal 15843 Taylor and Francis Ltd. 23 1.28
Modern Language Journal journal 918 Wiley-Blackwell 103 3.89
Journal of Sociolinguistics journal 5409 Wiley-Blackwell Publishing Ltd 61 1.96
Tekstilec trade journal 19217 Faculty of Natural Sciences and Engineering, Tekstilec 14 0.73
Korean Journal of Applied Microbiology and Biotechnology journal 22033 Korean Society for Applied Microbiology 0 0.00

Check complete list




Year wise Impact Score (IS) of Cardiovascular and Hematological Agents in Medicinal Chemistry

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.37
2021 2.06
2020 1.85
2019 1.31
2018 1.03
2017 0.81
2016 0.70
2015 0.84
2014 1.23



Top Journals/Conferences in Cardiology and Cardiovascular Medicine

Journal of the American College of Cardiology
Elsevier USA | United States

Circulation
Lippincott Williams and Wilkins Ltd. | United States

JAMA Cardiology
American Medical Association | United States

Nature Reviews Cardiology
Nature Publishing Group | United Kingdom

European Journal of Heart Failure
Wiley-Blackwell | United States

JACC: Heart Failure
Elsevier BV | Netherlands

Circulation Research
Lippincott Williams and Wilkins Ltd. | United States

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

European Heart Journal
Oxford University Press | United Kingdom

Circulation: Heart Failure
Lippincott Williams and Wilkins Ltd. | United States

See All

Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood
Elsevier BV | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Leukemia
Nature Publishing Group | United Kingdom

Journal of Thrombosis and Haemostasis
Wiley-Blackwell Publishing Ltd | United Kingdom

Blood advances
Elsevier BV | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All